Metraipolis › archive › dc_fac6565d4682

Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities — Europe PMC PMID:41323732

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41323732
DOI
10.3389/fcell.2025.1685857
License (as archived)
solo-consultazione
Archived
2026-11-08T14:04:45.298Z
SHA-256 of the archived text
21efb9e351b5d83f8f92b60d8925ddfe239d8d050d1a68f12edfe3cec6f408e5
Stable URL of this page
https://metraipolis.com/documento/dc_fac6565d4682

How to cite

Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities — Europe PMC PMID:41323732 — Europe PMC (en), https://europepmc.org/article/MED/41323732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fac6565d4682 (Metraipolis archive dc_fac6565d4682, sha256 21efb9e351b5d83f8f92b60d8925ddfe239d8d050d1a68f12edfe3cec6f408e5)
BibTeX
@misc{dcfac6565d4682,
  title = {Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities — Europe PMC PMID:41323732},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41323732},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fac6565d4682; sha256 21efb9e351b5d83f8f92b60d8925ddfe239d8d050d1a68f12edfe3cec6f408e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41323732. Agents can read the archived copy with the MCP tool read_document.